HEPATITIS B
Merilisa HBsAg is an in-vitro enzyme immunoassay for the qualitative determination of Hepatitis B surface antigen in human serum or plasma using HBsAg specific antibodies.
- One Step antigen sandwich assay
- Use of polyclonal antibodies
- Negative control based cut off
Benefits
01
High Analytical sensitivity
02
Detects all genotypes and phenotypes of HBV
03
No sample dilution required
Indication:
- Detection of HBsAg antigen in human serum or plasma
Product Specifications
| Intended Use | One step qualitative sandwich immunoassay for detection of Hepatitis 'B' surface antigen in human Serum and Plasma |
| Principle | Direct Sandwich Immunoassay |
| Technique | ELISA |
| Detection | Hepatitis B Surface Antigen |
| Capture | Anti - HBsAg antibodies (Polyclonal) |
| Conjugate | Monoclonal anti HBsAg conjugated with HRP |
| Type of Specimen required | Serum or Plasma |
| Total incubation time | 90 minutes |
| Diagnostic Sensitivity | 100% |
| Diagnostic Specificity | 100% |
| Evaluation | National Institute of Biologicals |
Ordering Information
| Product Code | Material Description | Pack Size |
|---|---|---|
| HPBELI-01 | Merilisa HBsAg | 96 Wells |
Clinical Data
Product IFU
Note: IFU will be displayed after MDR Certification